ConductScience.org, home

Paper40790282

Advances in PET imaging of protein aggregates associated with neurodegenerative disease.

Higuchi M and 3 others. Nat Rev Neurol, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Advances in PET imaging of protein aggregates associated with neurodegenerative disease. Papers, record 40790282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40790282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in PET imaging of protein aggregates associated with neurodegenerative disease.
PubMed
Journal
Nat Rev Neurol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.93, provisional
iCite
Revised in PubMed
2026-11-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Higuchi MMakotohttps://orcid.org/0000-0002-3934-5810
2Tagai KKenji
3Takahata KKeisuke
4Endo HHironobuhttps://orcid.org/0000-0003-3398-597X

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neurodegenerative DiseasesMajor topic
Positron-Emission TomographyMajor topic
Protein AggregatesMajor topic
Protein Aggregation, PathologicalMajor topic
Humans
tau Proteins
Amyloid beta-Peptides
alpha-Synuclein

Source PubMed

Download CSV of topics

References177

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137663501A Fluorescent Probe as a Lead Compound for a Selective α-Synuclein PET Tracer: Development of a Library of 2-Styrylbenzothiazoles and Biological Evaluation of [18F]PFSB and [18F]MFSB.ACS Omega2023https://conductscience.org/library/papers/37663501PubMed
227314820[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than "off-target" binding.Ann Neurol2016https://conductscience.org/library/papers/27314820PubMed
332956648Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein.Brain Res2020https://conductscience.org/library/papers/32956648PubMed
425824567Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.Alzheimers Dement2015https://conductscience.org/library/papers/25824567PubMed
535344984Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.Nature2022https://conductscience.org/library/papers/35344984PubMed
625534025Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.Acta Neuropathol2015https://conductscience.org/library/papers/25534025PubMed
730938796Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.JAMA2019https://conductscience.org/library/papers/30938796PubMed
827997036Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.Ann Neurol2017https://conductscience.org/library/papers/27997036PubMed
930857558Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.Acta Neuropathol Commun2019https://conductscience.org/library/papers/30857558PubMed
1035513543Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.Acta Neuropathol2022https://conductscience.org/library/papers/35513543PubMed
1122749065Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.Lancet Neurol2012https://conductscience.org/library/papers/22749065PubMed
1230326496Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.JAMA2018https://conductscience.org/library/papers/30326496PubMed
1334089275Clinical Utility of 18 F-APN-1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy.Mov Disord2021https://conductscience.org/library/papers/34089275PubMed
1437421950Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies.Cell2023https://conductscience.org/library/papers/37421950PubMed
1531264169Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies.Eur J Nucl Med Mol Imaging2019https://conductscience.org/library/papers/31264169PubMed
1633165511Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.JAMA Neurol2020https://conductscience.org/library/papers/33165511PubMed
173267140818F-MK-6240 PET for early and late detection of neurofibrillary tangles.Brain2020https://conductscience.org/library/papers/32671408PubMed
1823234879Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.J Alzheimers Dis2013https://conductscience.org/library/papers/23234879PubMed
1928678775Cryo-EM structures of tau filaments from Alzheimer's disease.Nature2017https://conductscience.org/library/papers/28678775PubMed
2024860424Protein phosphorylation in neurodegeneration: friend or foe?Front Mol Neurosci2014https://conductscience.org/library/papers/24860424PubMed

See all 177 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42927299PET-based molecular imaging in neurodegeneration and dementia: current and emerging radiotracers.Radiol Adv2026https://conductscience.org/library/papers/42927299PubMed
42894080Radiosynthesis and quality control testing of two 18F-labeled radiopharmaceuticals for α-synuclein imaging in clinical investigations.EJNMMI Radiopharm Chem2026https://conductscience.org/library/papers/42894080PubMed
42720909Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring.Mol Diagn Ther2026https://conductscience.org/library/papers/42720909PubMed
42547799High prevalence of tau pathologies in late-onset psychosis: A PET study.Mol Psychiatry2026https://conductscience.org/library/papers/42547799PubMed
42394416Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.Alzheimers Dement2026https://conductscience.org/library/papers/42394416PubMed
41002384Imaging of Proteinopathies in the Brains of Parkinsonian Disorders.Cells2025https://conductscience.org/library/papers/41002384PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
FUS2521PubTator's text mininghttps://conductscience.org/library/genes/2521NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene
TARDBP23435PubTator's text mininghttps://conductscience.org/library/genes/23435NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40790282

GET https://conductscience.org/api/papers/v1/40790282/references?page=2